Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
82472651
Funder:
National Natural Science Foundation of China
Funded outputs count:
6
Funder award ID:
82472651
OpenAlex ID:
G414606867
Phase III Trial: Single Low-Dose 5 mg Dexamethasone with NEPA for Preventing 168 h Nausea and Vomiting of Diverse Highly or Moderately Emetogenic Chemotherapy (LD-NEPA)
2026
·
Yuting He
, Xintian Huang
, et al.
·
Diseases
FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3‐Mediated ErbB3 Fucosylation in Lung Adenocarcinoma
2026
·
Lu Chen
, Jintao Guo
, et al.
·
Advanced Science
·
1
YTHDC1 drives senescence evasion in ovarian cancer through m6A-mediated TERT stabilization
2026
·
Fen Wang
, Zhengyang Zhao
, et al.
·
Cell Death and Disease
·
2
PDF
HNF4α-Mediated LINC02560 Promotes Papillary Thyroid Carcinoma Progression by Targeting the miR-505-5p/PDE4C Axis
2025
·
Yongcheng Su
, Beibei Xu
, et al.
·
Biomolecules
·
2
PDF
The Role of Long Non-Coding RNAs in Modulating the Immune Microenvironment of Triple-Negative Breast Cancer: Mechanistic Insights and Therapeutic Potential
2025
·
Yongcheng Su
, Qingquan Bai
, et al.
·
Biomolecules
·
13
Deeper Analysis to Identify the True Benefit of ICIs Immunotherapy in First-Line Treatment for Non-HER2-Positive/HER2-Negative Advanced or Metastatic Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)
2025
·
Bowen Zheng
, Fanzhuoran Lou
, et al.
·
Cancers
PDF
Show more works
View as search